Literature DB >> 7435932

Plasma cholinesterase changes during pregnancy. Their interpretation as a cause of suxamethonium-induced apnoea.

R T Evans, J M Wroe.   

Abstract

Cholinesterase activities were measured on serum from 941 pregnant women distributed evenly throughout the 40 weeks of gestation. A rapid fall has been shown to occur during the first trimester to a level which did not alter significantly during the remainder of pregnancy. Even lower values were observed in 105 patients examined during the first 7 days following delivery. Enzyme activity was used to determine the probable incidence of a prolonged reaction to suxamethonium in obstetric patients. The risk was greatest in the immediate post partum period affecting 11% of the patients investigated.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7435932     DOI: 10.1111/j.1365-2044.1980.tb03878.x

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  5 in total

Review 1.  Clinical pharmacokinetics of neuromuscular relaxants in pregnancy.

Authors:  J Guay; Y Grenier; F Varin
Journal:  Clin Pharmacokinet       Date:  1998-06       Impact factor: 6.447

2.  Cholinesterase activities in uterus of normal and fenchlorphos treated blue foxes (Alopex lagopus) during various reproductive states.

Authors:  G N Berge; S H Sterri; N E Søli
Journal:  Acta Vet Scand       Date:  1988       Impact factor: 1.695

3.  On the identification and frequency of the J and K cholinesterase phenotypes in a Caucasian population.

Authors:  R T Evans; J Wardell
Journal:  J Med Genet       Date:  1984-04       Impact factor: 6.318

Review 4.  The use of muscle relaxants in the intensive care unit.

Authors:  M D Sharpe
Journal:  Can J Anaesth       Date:  1992-11       Impact factor: 5.063

5.  Gestational diabetes mellitus (GDM) decreases butyrylcholinesterase (BChE) activity and changes its relationship with lipids.

Authors:  Larissa O Guimarães; Fabiana A de Andrade; Gleyse F Bono; Thaís E Setoguchi; Mariana B Brandão; Eleidi A Chautard-Freire-Maia; Izabella C R Dos Santos; Geraldo Picheth; Ana Cristina R de A Faria; Rosângela R Réa; Ricardo L R Souza; Lupe Furtado-Alle
Journal:  Genet Mol Biol       Date:  2013-02-28       Impact factor: 1.771

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.